bendazac-lysine has been researched along with Diabetes-Mellitus--Type-1* in 2 studies
1 trial(s) available for bendazac-lysine and Diabetes-Mellitus--Type-1
Article | Year |
---|---|
Vitreous fluorophotometry and changes in blood-retinal barrier permeability induced by bendazac lysine.
Vitreous fluorophotometry was used to investigate the effect of Bendazac lysine on the blood retinal barrier in 12 insulin-dependent diabetics with mild background retinopathy. The study was a randomized, double blind, cross-over trial, drug versus Placebo. Each treatment period was of 4 months. The vitreous penetration coefficient was reduced by 21% (95% c.i. 12, 30; p = 0.001) by treatment with respect to Placebo. Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood-Retinal Barrier; Cell Membrane Permeability; Cross-Over Studies; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Fluorescein; Fluoresceins; Fluorescent Dyes; Fluorophotometry; Follow-Up Studies; Humans; Indazoles; Male; Middle Aged; Sample Size; Vitreous Body | 1997 |
1 other study(ies) available for bendazac-lysine and Diabetes-Mellitus--Type-1
Article | Year |
---|---|
Improvement of the blood-retinal barrier induced by bendazac lysine: preliminary clinical observation in insulin-dependent diabetics.
Topics: Adult; Blood-Retinal Barrier; Diabetes Mellitus, Type 1; Female; Humans; Indazoles; Male; Middle Aged; Pyrazoles | 1987 |